Skip Navigation

Pilot of Osanetant to Reduce Testosterone in Men with Adenocarcinoma of the Prostate PORT-MAP

Brief Summary

Type:
Prostate

Study Type:
Treatment

Phase:
Feasibility/Pilot

ClinicalTrials.gov Identifier:
NCT05607342

Study #:
STUDY00148767

Start Date:
Nov 06, 2022

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05607342

View Complete Trial Details & Eligibility at ClinicalTrials.gov